Exact Mass: 499.0968632000001

Exact Mass Matches: 499.0968632000001

Found 35 metabolites which its exact mass value is equals to given mass value 499.0968632000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

VX-11e

4-{2-[(2-Chloro-4-Fluorophenyl)amino]-5-Methylpyrimidin-4-Yl}-N-[(1s)-1-(3-Chlorophenyl)-2-Hydroxyethyl]-1h-Pyrrole-2-Carboxamide

C24H20Cl2FN5O2 (499.0978012)


VX-11e is a potent, selective, and orally bioavailable inhibitor of ERK with Ki < 2 nM.

   

CDK9 inhibitor

N-[5-({6-[3-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)phenyl]pyrimidin-4-yl}amino)-2-methylphenyl]methanesulphonamide

C26H21N5O4S (499.1314186000001)


   

Glucose lactate pyruvate glutamate

2-Amino-5-[(2-hydroxypropanoyl)peroxy]-5-oxo-2-[2,3,4,5-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl]pentanoyl 2-oxopropaneperoxoic acid

C17H25NO16 (499.11732900000004)


   

Palygorskite

Dialumane tetradecahydric acid dimagnesium tetrasilane hydroxide

Al2H45Mg2O15Si4 (499.116726)


It is used in foods as a clarifying and flocculating agent [DFC]

   

3,4,5-Trimethoxybenzyl glucosinolate

3,4,5-Trimethoxybenzyl glucosinolate

C17H25NO12S2 (499.081813)


   
   
   
   

3-[(4-Methyl-3,5-dinitrophenyl)sulfonyl]-2-(2,4,5-trimethoxypheny l)-1,3-thiazolidine

3-[(4-Methyl-3,5-dinitrophenyl)sulfonyl]-2-(2,4,5-trimethoxypheny l)-1,3-thiazolidine

C19H21N3O9S2 (499.07191760000006)


   

Fosquidone

Fosquidone

C28H22NO6P (499.11846820000005)


C274 - Antineoplastic Agent > C177298 - Mitochondrial Targeting Antineoplastic Agent C26170 - Protective Agent > C275 - Antioxidant

   

4-nitrobenzyl [2R-(2alpha,5beta,6alpha,7beta)]-3-methylene-8-oxo-7-(phenoxyacetamido)-5-thia-1-azabicyclo[4.2.0]octane-2-carboxylate 5-oxide

4-nitrobenzyl [2R-(2alpha,5beta,6alpha,7beta)]-3-methylene-8-oxo-7-(phenoxyacetamido)-5-thia-1-azabicyclo[4.2.0]octane-2-carboxylate 5-oxide

C23H21N3O8S (499.10493060000005)


   
   

Sodelglitazar

2-[4-[[2-[2-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl]methylsulfanyl]-2-methylphenoxy]-2-methylpropanoic acid

C23H21F4NO3S2 (499.0898924)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist

   

N-{2-[4-(aminosulfonyl)phenyl]ethyl}-2-[(2-isopropyl-3-oxo-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)thio]acetamide

N-{2-[4-(aminosulfonyl)phenyl]ethyl}-2-[(2-isopropyl-3-oxo-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)thio]acetamide

C23H25N5O4S2 (499.134789)


   

Azane;cyclohexanamine;platinum(4+);diacetate;dichloride

Azane;cyclohexanamine;platinum(4+);diacetate;dichloride

C10H22Cl2N2O4Pt (499.0604402)


   

n-[4-[[Glutamic acid]-carbonyl]-benzene-sulfonyl-d-prolinyl]-3-amino-propanoic acid

n-[4-[[Glutamic acid]-carbonyl]-benzene-sulfonyl-d-prolinyl]-3-amino-propanoic acid

C20H25N3O10S (499.12605900000005)


   

3-(5-Amino-7-hydroxy-[1,2,3]triazolo[4,5-D]pyrimidin-2-YL)-N-[2-(2-(hydroxymethyl-phenylsulfanyl)-benzyl]-benzamide

3-(5-Amino-7-hydroxy-[1,2,3]triazolo[4,5-D]pyrimidin-2-YL)-N-[2-(2-(hydroxymethyl-phenylsulfanyl)-benzyl]-benzamide

C25H21N7O3S (499.1426516)


   
   

(2R)-2-amino-4-{4-[(1E)-{[(3S)-1-[(R)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl}(hydroxyimino)methyl]phenoxy}butanoate

(2R)-2-amino-4-{4-[(1E)-{[(3S)-1-[(R)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl}(hydroxyimino)methyl]phenoxy}butanoate

C23H23N4O9- (499.1464968)


   
   

(2S)-2-amino-4-{4-[(1E)-{[(3S)-1-[(R)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl}(hydroxyimino)methyl]phenoxy}butanoate

(2S)-2-amino-4-{4-[(1E)-{[(3S)-1-[(R)-carboxy(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl}(hydroxyimino)methyl]phenoxy}butanoate

C23H23N4O9- (499.1464968)


   

2-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxypropanoic acid

2-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxypropanoic acid

C13H19N5O12P2 (499.0505434)


   

5-O-(2-hydroxypropanoyl) 1-O-(2-oxopropanoyl) 2-amino-2-[2,3,4,5-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl]pentanediperoxoate

5-O-(2-hydroxypropanoyl) 1-O-(2-oxopropanoyl) 2-amino-2-[2,3,4,5-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl]pentanediperoxoate

C17H25NO16 (499.11732900000004)


   

(2S)-2-[3-[3-(trifluoromethyl)-4-[[4-(trifluoromethyl)phenyl]methoxy]phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carboximidamide

(2S)-2-[3-[3-(trifluoromethyl)-4-[[4-(trifluoromethyl)phenyl]methoxy]phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidine-1-carboximidamide

C22H19F6N5O2 (499.14428660000004)


   

N-(1,3-benzodioxol-5-ylmethyl)-1-ethyl-6-(4-morpholinylsulfonyl)-4-oxo-3-quinolinecarboxamide

N-(1,3-benzodioxol-5-ylmethyl)-1-ethyl-6-(4-morpholinylsulfonyl)-4-oxo-3-quinolinecarboxamide

C24H25N3O7S (499.141314)


   

[4-(2-Chlorophenyl)sulfonyl-3-nitrophenyl]-[4-(phenylmethyl)-1-piperazinyl]methanone

[4-(2-Chlorophenyl)sulfonyl-3-nitrophenyl]-[4-(phenylmethyl)-1-piperazinyl]methanone

C24H22ClN3O5S (499.0968632000001)


   

3-[[2-[[5-[(4-Cyanophenoxy)methyl]-4-phenyl-1,2,4-triazol-3-yl]thio]-1-oxoethyl]amino]benzoic acid methyl ester

3-[[2-[[5-[(4-Cyanophenoxy)methyl]-4-phenyl-1,2,4-triazol-3-yl]thio]-1-oxoethyl]amino]benzoic acid methyl ester

C26H21N5O4S (499.1314186000001)


   

4-(4-Chlorobenzoyl)-1-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-5-phenylpyrrolidine-2,3-dione

4-(4-Chlorobenzoyl)-1-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-5-phenylpyrrolidine-2,3-dione

C28H22ClN3O4 (499.12987620000007)


   

(2R)-2-amino-4-[4-[(Z)-C-[[(3S)-1-[(R)-carboxy-(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl]-N-oxidocarbonimidoyl]phenoxy]butanoic acid

(2R)-2-amino-4-[4-[(Z)-C-[[(3S)-1-[(R)-carboxy-(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl]-N-oxidocarbonimidoyl]phenoxy]butanoic acid

C23H23N4O9- (499.1464968)


   

(2S)-2-amino-4-[4-[(Z)-C-[[(3S)-1-[(R)-carboxy-(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl]-N-oxidocarbonimidoyl]phenoxy]butanoic acid

(2S)-2-amino-4-[4-[(Z)-C-[[(3S)-1-[(R)-carboxy-(4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]carbamoyl]-N-oxidocarbonimidoyl]phenoxy]butanoic acid

C23H23N4O9- (499.1464968)


   

nocardicin A(1-)

nocardicin A(1-)

C23H23N4O9 (499.1464968)


An alpha-amino-acid anion that is the conjugate base of nocardicin A, arising from deprotonation of the carboxy groups and protonation of the amino group.

   

isonocardicin A(1-)

isonocardicin A(1-)

C23H23N4O9 (499.1464968)


Conjugate base of isonocardicin A zwitterion where both carboxy groups are deprotonated while the homoserine amino group is protonated.

   

(R)-VX-11e

(R)-VX-11e

C24H20Cl2FN5O2 (499.0978012)


(R)-VX-11e (Compound 1) is an ERK2 inhibitor[1].